A Potential Therapeutic Target for Steroid Resistant Asthma,” published in the December 2024 issue of Allergy and Immunology ...

A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

"We are also supporting more appropriate prescribing of medicines and the development of national pathways for severe asthma care." ...

A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric ...

This syndrome is referred to as aspirin-induced asthma (AIA). The pathogenesis of AIA has implicated both the lipoxygenase (LO) and the cyclooxygenase (COX) pathways. By inhibiting the COX pathway ...

Discover findings that show the potential of nasal transcriptomic profiling to classify asthma into endotypes, which could ...

It is currently being tested against acute graft-vs-host disease (aGVHD), lupus nephritis, and uncontrolled asthma ... Studies have shown the CD6-ALCAM pathway is overactive in the inflamed ...